Cargando…
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
Lung cancer is a major public health problem in the western world, and gene therapy strategies to tackle this disease systemically are often impaired by inefficient delivery of the vector to the tumour tissue. Some of the main factors inhibiting systemic delivery are found in the blood stream in the...
Autores principales: | Mohr, Andrea, Lyons, Mark, Deedigan, Laura, Harte, Tina, Shaw, Georgina, Howard, Linda, Barry, Frank, O'Brien, Tim, Zwacka, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828879/ https://www.ncbi.nlm.nih.gov/pubmed/18373740 http://dx.doi.org/10.1111/j.1582-4934.2008.00317.x |
Ejemplares similares
-
Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects
por: Yu, R, et al.
Publicado: (2013) -
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
por: Mohr, Andrea, et al.
Publicado: (2015) -
MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells
por: Mohr, Andrea, et al.
Publicado: (2019) -
Generation of magnetic biohybrid microrobots based on MSC.sTRAIL for targeted stem cell delivery and treatment of cancer
por: Gundersen, Rebekah Anamarie, et al.
Publicado: (2023) -
Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
por: Arora, Jigyasa, et al.
Publicado: (2015)